Iain D. Dukes
CIK 1681955 · Chief Executive Officer · last filed 2026-07-14
Iain D. Dukes is a Chief Executive Officer who has filed 32 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing, for TRAW, was dated Jul 14, 2026. Across all open-market trades the lifetime net is +$457.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $375.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$375.3K
5
32
$457.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRAW | Chief Executive Officer | 236,934 | $0.51 | $121.5K | $0 | 6 | 2026-07-14 |
| IOVA | Director | 54,000 | $4.70 | $253.8K | $457.6K | 14 | 2026-06-18 |
| ImageneBio, Inc. (IKNA) Delisted | Director | — | $17.16 | — | $0 | 4 | 2024-06-10 |
| Theseus Pharmaceuticals, Inc. (THRX) Delisted | Chairman | 0 | $4.06 | $0 | $0 | 4 | 2024-02-14 |
| IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted | Director | — | — | — | $0 | 3 | 2017-06-05 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-14 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2026-06-18 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2026-03-10 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2025-12-16 | TRAW | Grant (A) | +36,943 | $0 | EDGAR |
| 2025-10-15 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2025-06-17 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2024-11-05 | — | Grant (A) | — | $0 | |
| 2024-08-07 | TRAW | Grant (A) | +67,500 | $0 | EDGAR |
| 2024-06-13 | IOVA | Grant (A) | — | $0 | EDGAR |
| 2024-06-10 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.